Concert Pharmaceuticals
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
65 Hayden Ave Ste 3000N, Lexington, Mass...Phone Number
(781) 860-0045Website
www.concertpharma.comRevenue
$32.6 MillionIndustry
About Concert Pharmaceuticals
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to treat serious diseases and address unmet patient needs. The Company's approach starts with previously studied compounds, including approved drugs, in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert's pipeline of innovative medicines targets autoimmune diseases and central nervous systems (CNS) disorders.Explore more
SIC Code 87,873NAICS Code 54,541Show moreConcert Pharmaceuticals Org Chart
Compare Similar Companies to Concert Pharmaceuticals
Compare insights from companies similar to Concert Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Concert Pharmaceuticals Tech Stack
A closer look at the technologies used by Concert Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Concert Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to treat serious diseases and address unmet patient needs. The Company's approach starts with previously studied compounds, including approved drugs, in which deuterium... Read More